Table 1.
Correlation between SPRY4-IT1 expression and clinicopathological features in patients with breast cancer
| SPRY4-IT1 expression | P Value | ||
|---|---|---|---|
|
| |||
| Low (n = 50) | High (n = 52) | ||
| Age | 0.237 | ||
| ≤ 50 | 23 | 30 | |
| > 50 | 27 | 22 | |
| Menopausal status | 0.698 | ||
| Premenopausal | 25 | 24 | |
| Postmenopausal | 25 | 28 | |
| Tumor size | 0.009 | ||
| ≤ 2 cm | 27 | 15 | |
| > 2 cm | 23 | 37 | |
| Lymph node status | 0.01 | ||
| Negative | 30 | 18 | |
| Positive | 20 | 34 | |
| Grade | 0.672 | ||
| I-II | 21 | 24 | |
| III | 29 | 28 | |
| ER status | 0.237 | ||
| Negative | 23 | 30 | |
| Positive | 27 | 22 | |
| PR | 0.239 | ||
| Negative | 24 | 31 | |
| Positive | 26 | 21 | |
| HER-2/neu status | 0.538 | ||
| Negative | 29 | 27 | |
| Positive | 21 | 25 | |
| Clinical stage | 0.0008 | ||
| I-II | 40 | 25 | |
| III | 10 | 27 | |